Telix Pharmaceuticals (TLX) Goodwill & Intangibles (2023 - 2025)

Telix Pharmaceuticals (TLX) has disclosed Goodwill & Intangibles for 3 consecutive years, with $791.8 million as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 133.77% to $791.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $791.8 million through Dec 2025, up 133.77% year-over-year, with the annual reading at $791.8 million for FY2025, 190.96% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $791.8 million at Telix Pharmaceuticals, up from $338.7 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $791.8 million in Q4 2025, with the low at $71.4 million in Q4 2023.
  • Average Goodwill & Intangibles over 3 years is $400.6 million, with a median of $338.7 million recorded in 2024.
  • The sharpest move saw Goodwill & Intangibles soared 374.47% in 2024, then skyrocketed 133.77% in 2025.
  • Over 3 years, Goodwill & Intangibles stood at $71.4 million in 2023, then skyrocketed by 374.47% to $338.7 million in 2024, then soared by 133.77% to $791.8 million in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $791.8 million, $338.7 million, and $71.4 million for Q4 2025, Q4 2024, and Q4 2023 respectively.